Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 935

1.

Resistance Exercise Reduces Kynurenine Pathway Metabolites in Breast Cancer Patients Undergoing Radiotherapy.

Zimmer P, Schmidt ME, Prentzell MT, Berdel B, Wiskemann J, Kellner KH, Debus J, Ulrich C, Opitz CA, Steindorf K.

Front Oncol. 2019 Sep 25;9:962. doi: 10.3389/fonc.2019.00962. eCollection 2019.

2.

Dosimetric Impact of Interfractional Variations in Prostate Cancer Radiotherapy-Implications for Imaging Frequency and Treatment Adaptation.

Bostel T, Sachpazidis I, Splinter M, Bougatf N, Fechter T, Zamboglou C, Jäkel O, Huber PE, Baltas D, Debus J, Nicolay NH.

Front Oncol. 2019 Sep 27;9:940. doi: 10.3389/fonc.2019.00940. eCollection 2019.

3.

Development and validation of single field multi-ion particle therapy treatments.

Kopp B, Mein S, Dokic I, Harrabi S, Böhlen TT, Haberer T, Debus J, Abdollahi A, Mairani A.

Int J Radiat Oncol Biol Phys. 2019 Oct 11. pii: S0360-3016(19)33879-9. doi: 10.1016/j.ijrobp.2019.10.008. [Epub ahead of print]

4.

The Phase I/II ACCEPT Trial: Concurrent Cetuximab and Intensity-Modulated Radiotherapy with Carbon Ion Boost for Adenoid Cystic Carcinoma of the Head and Neck: Cetuximab and IMRT/Carbon Ions for ACC.

Adeberg S, Akbaba S, Lang K, Held T, Verma V, Nikoghosyan A, Bernhardt D, Münter M, Freier K, Plinkert P, Hauswald H, Herfarth K, Rieken S, Debus J, Jensen AD.

Int J Radiat Oncol Biol Phys. 2019 Oct 3. pii: S0360-3016(19)33860-X. doi: 10.1016/j.ijrobp.2019.09.036. [Epub ahead of print]

PMID:
31586664
5.

Overexpression of p16INK4a Serves as Prognostic Marker in Squamous Cell Vulvar Cancer Patients Treated With Radiotherapy Irrespective of HPV-Status.

Arians N, Prigge ES, Nachtigall T, Reuschenbach M, Koerber SA, Debus J, von Knebel Doeberitz M, Lindel K.

Front Oncol. 2019 Sep 11;9:891. doi: 10.3389/fonc.2019.00891. eCollection 2019.

6.

Offline imaging of positron emitters induced by therapeutic helium, carbon and oxygen ion beams with a full-ring PET/CT scanner: experiments in reference targets.

Bauer J, Tessonnier T, Debus J, Parodi K.

Phys Med Biol. 2019 Sep 27. doi: 10.1088/1361-6560/ab48b4. [Epub ahead of print]

PMID:
31561234
7.

Second breast conserving therapy after ipsilateral breast tumor recurrence - a 10-year experience of re-irradiation.

Forster T, Akbaba S, Schmitt D, Krug D, El Shafie R, Oelmann-Avendano J, Lindel K, König L, Arians N, Bernhardt D, Marmé F, Schneeweiss A, Heil J, Sohn C, Debus J, Hörner-Rieber J.

J Contemp Brachytherapy. 2019 Aug;11(4):312-319. doi: 10.5114/jcb.2019.87001. Epub 2019 Aug 29.

8.

Overcoming radioresistance in WiDr cells with heavy ion irradiation and radiosensitization by 2-deoxyglucose with photon irradiation.

Hasse FC, Koerber SA, Prigge ES, Liermann J, von Knebel Doeberitz M, Debus J, Sterzing F.

Clin Transl Radiat Oncol. 2019 Aug 20;19:52-58. doi: 10.1016/j.ctro.2019.08.003. eCollection 2019 Nov.

9.

Dosimetric validation of Monte Carlo and analytical dose engines with raster-scanning 1H, 4He, 12C, and 16O ion-beams using an anthropomorphic phantom.

Mein S, Kopp B, Tessonnier T, Ackermann B, Ecker S, Bauer J, Choi K, Aricò G, Ferrari A, Haberer T, Debus J, Abdollahi A, Mairani A.

Phys Med. 2019 Aug;64:123-131. doi: 10.1016/j.ejmp.2019.07.001. Epub 2019 Jul 11.

PMID:
31515011
10.

Active-Scanned Protons and Carbon Ions in Cancer Treatment of Patients With Cardiac Implantable Electronic Devices: Experience of a Single Institution.

Seidensaal K, Harrabi SB, Scholz E, Ellerbrock M, Haberer T, Weykamp F, Mattke M, Welte SE, Herfarth K, Debus J, Uhl M.

Front Oncol. 2019 Aug 22;9:798. doi: 10.3389/fonc.2019.00798. eCollection 2019.

11.

The impact of age on the outcome of patients treated with radiotherapy for mucoepidermoid carcinoma (MEC) of the salivary glands in the head and neck: A 15-year single-center experience.

Akbaba S, Heusel A, Mock A, Held T, Lang K, Hoerner-Rieber J, Forster T, Katayama S, Kargus S, Rieken S, Plinkert P, Herfarth K, Debus J, Adeberg S.

Oral Oncol. 2019 Oct;97:115-123. doi: 10.1016/j.oraloncology.2019.08.018. Epub 2019 Sep 5.

PMID:
31494395
12.

Treatment Outcome of a Combined Dose-Escalated Treatment Regime With Helical TomoTherapy® and Active Raster-Scanning Carbon Ion Boost for Adenocarcinomas of the Head and Neck.

Akbaba S, Mock A, Hoerner-Rieber J, Held T, Katayama S, Forster T, Freudlsperger C, Rieken S, Herfarth K, Plinkert P, Debus J, Adeberg S.

Front Oncol. 2019 Aug 13;9:755. doi: 10.3389/fonc.2019.00755. eCollection 2019.

13.

Elective Node Irradiation With Integrated Boost to the Prostate Using Helical IMRT-Clinical Outcome of the Prospective PLATIN-1 Trial.

Koerber SA, Winter E, Katayama S, Slynko A, Haefner MF, Uhl M, Sterzing F, Habl G, Schubert K, Debus J, Herfarth K.

Front Oncol. 2019 Aug 13;9:751. doi: 10.3389/fonc.2019.00751. eCollection 2019.

14.

Clinical applications of proton and carbon ion therapy.

Rackwitz T, Debus J.

Semin Oncol. 2019 Jun;46(3):226-232. doi: 10.1053/j.seminoncol.2019.07.005. Epub 2019 Aug 13. Review.

PMID:
31451309
15.

Abnormal mast cells in myeloid neoplasm with eosinophilia and PDGFRB rearrangement.

Bourrienne MC, Debus J.

Blood. 2019 Aug 22;134(8):718. doi: 10.1182/blood.2019000588. No abstract available.

PMID:
31439618
16.

Mesenchymal stem cells preserve their stem cell traits after exposure to antimetabolite chemotherapy.

Lopez Perez R, Münz F, Vidoni D, Rühle A, Trinh T, Sisombath S, Zou B, Wuchter P, Debus J, Grosu AL, Saffrich R, Huber PE, Nicolay NH.

Stem Cell Res. 2019 Oct;40:101536. doi: 10.1016/j.scr.2019.101536. Epub 2019 Aug 13.

17.

IDH-wildtype glioblastomas and grade III/IV IDH-mutant gliomas show elevated tracer uptake in fibroblast activation protein-specific PET/CT.

Röhrich M, Loktev A, Wefers AK, Altmann A, Paech D, Adeberg S, Windisch P, Hielscher T, Flechsig P, Floca R, Leitz D, Schuster JP, Huber PE, Debus J, von Deimling A, Lindner T, Haberkorn U.

Eur J Nucl Med Mol Imaging. 2019 Aug 6. doi: 10.1007/s00259-019-04444-y. [Epub ahead of print]

PMID:
31388723
18.

Post-Mastectomy Radiotherapy After Neoadjuvant Chemotherapy in Breast Cancer: A Pooled Retrospective Analysis of Three Prospective Randomized Trials.

Krug D, Lederer B, Seither F, Nekljudova V, Ataseven B, Blohmer JU, Costa SD, Denkert C, Ditsch N, Gerber B, Hanusch C, Heil J, Hilfrich J, Huober JB, Jackisch C, Kümmel S, Paepke S, Schem C, Schneeweiss A, Untch M, Debus J, von Minckwitz G, Kühn T, Loibl S.

Ann Surg Oncol. 2019 Nov;26(12):3892-3901. doi: 10.1245/s10434-019-07635-x. Epub 2019 Jul 26.

PMID:
31350646
19.

Carbon Ion Reirradiation for Recurrent Head and Neck Cancer: A Single-Institutional Experience.

Held T, Windisch P, Akbaba S, Lang K, El Shafie R, Bernhardt D, Plinkert P, Kargus S, Rieken S, Herfarth K, Debus J, Adeberg S.

Int J Radiat Oncol Biol Phys. 2019 Jul 23. pii: S0360-3016(19)33504-7. doi: 10.1016/j.ijrobp.2019.07.021. [Epub ahead of print]

PMID:
31349059
20.

Carbon-ion irradiation overcomes HPV-integration/E2 gene-disruption induced radioresistance of cervical keratinocytes.

Arians N, Nicolay NH, Brons S, Koerber SA, Jaschke C, Vercruysse M, Daffinger S, Rühle A, Debus J, Lindel K.

J Radiat Res. 2019 Jul 19. pii: rrz048. doi: 10.1093/jrr/rrz048. [Epub ahead of print]

PMID:
31322705

Supplemental Content

Loading ...
Support Center